PDF) Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
Startups Financiadas por Ship2B o su Red | Ship2B Foundation
Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring.
Altum sequencing – Following the genetic trail of cancer – Altum sequencing is a biomedical company specializing in the identification of patient specific genetic markers suitable for MRD monitoring.
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial - The Lancet Respiratory Medicine
Cancers | Free Full-Text | Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study - Ayala - eJHaem - Wiley Online Library
Technology – Altum sequencing – Following the genetic trail of cancer
Similar companies to 24 genetics | EIT Health Startups
Exaltum - News&Press
Altum sequencing | LinkedIn
UC3M Science Park BUSINESS INCUBATOR
Altum Sequencing S.L. | UC3M
Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches - ScienceDirect
A system for the early detection of tumour cells has been developed at UC3M - Yerun
Courses: „Statistics and R“ and „Next generation sequencing analysis“ - Biocentar